Home/Filings/4/0001062993-25-012617
4//SEC Filing

TAYLOR GLEN A 4

Accession 0001062993-25-012617

CIK 0001840877other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 10:37 AM ET

Size

17.9 KB

Accession

0001062993-25-012617

Insider Transaction Report

Form 4
Period: 2025-06-26
TAYLOR GLEN A
Director10% Owner
Transactions
  • Award

    Warrant (right to buy)

    2025-06-26+750,000750,000 total(indirect: By LLC)
    Exercise: $1.48From: 2025-06-26Exp: 2027-06-26Class A Common Stock (750,000 underlying)
Holdings
  • Series A Preferred Stock

    (indirect: By LLC)
    Exercise: $11.50Class A Common Stock (869,565 underlying)
    1,000,000
  • Class A Common Stock

    (indirect: By Taylor Sports Group)
    2,526,058
  • Warrant (right to buy)

    (indirect: By LLC)
    Exercise: $3.04From: 2024-05-23Exp: 2026-02-27Class A Common Stock (250,000 underlying)
    250,000
  • Warrant (right to buy)

    (indirect: By LLC)
    Exercise: $2.25From: 2024-07-22Exp: 2026-02-27Class A Common Stock (250,000 underlying)
    250,000
  • Warrant (right to buy)

    (indirect: By LLC)
    Exercise: $2.20From: 2024-12-11Exp: 2026-08-27Class A Common Stock (500,000 underlying)
    500,000
  • Class A Common Stock

    2,953,607
  • Warrant (right to buy)

    (indirect: By LLC)
    Exercise: $1.24From: 2024-02-27Exp: 2026-02-27Class A Common Stock (500,000 underlying)
    500,000
  • Warrant (right to buy)

    (indirect: By LLC)
    Exercise: $2.97From: 2024-08-27Exp: 2026-08-27Class A Common Stock (500,000 underlying)
    500,000
  • Class A Common Stock

    (indirect: By LLC)
    4,810,384
  • Warrant (right to buy)

    (indirect: By LLC)
    Exercise: $1.35From: 2025-03-11Exp: 2028-03-11Class A Common Stock (750,000 underlying)
    750,000
Footnotes (4)
  • [F1]The Reporting Person is the owner and chairman of Taylor Sports Group.
  • [F2]GAT Funding, LLC is an entity controlled by the Reporting Person.
  • [F3]Fully exercisable and there is no expiration date.
  • [F4]In connection with the promissory note issuance effective March 6, 2025 and the closing of the final funding on June 26, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on July 2, 2025.

Issuer

Envoy Medical, Inc.

CIK 0001840877

Entity typeother

Related Parties

1
  • filerCIK 0001213971

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 10:37 AM ET
Size
17.9 KB